Abstract RF7-07: Adjuvant Palbociclib for ER+ Breast Cancer in the PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): Post-Recurrence Treatment and Overall Survival
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: A. DeMichele, A. Dueck, M. Gnant, D. Hlauschek, M. Martin, A. Wolff, G. Rubovsky, F. Henao, O. Hahn, A. Chan, A. Brusky, P. Morris, H. Burstein, G. Huber, D. Anderson, L. Garcia-Estevez, G. Pfeiler, H. Rugo, N. Zdenkowski, S. Gampenrieder, N. Wolmark, D. Sabanathan, K. Miller, D. Cameron, E. Winer, C. Brunner, E. Gauthier, P. O’Brien, C. Fesl, E. Mayer
Institutions: University of Pennsylvania, Mayo Clinic in Arizona, Medical University of Vienna, Austrian Breast & Colorectal Cancer Study Group, Hospital General Universitario Gregorio Marañón, Johns Hopkins University, National Institute of Oncology, Hospital Universitario Virgen Macarena, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, University of Pittsburgh, Beaumont Hospital, Dana-Farber Cancer Institute, Metro-Minnesota Community Oncology Research Consortium, MD Anderson Cancer Center Madrid, University of San Francisco, Calvary Mater Newcastle Hospital, NSABP Foundation, Macquarie University, Indiana University Indianapolis, Edinburgh Cancer Research, Yale University, Innsbruck Medical University, Pfizer (United States), Mayo Clinic
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129247684
Cites:
Cited by:
Related to: